216 related articles for article (PubMed ID: 33849622)
1. Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs).
Lin L; Kuhn C; Ditsch N; Kolben T; Czogalla B; Beyer S; Trillsch F; Schmoeckel E; Mayr D; Mahner S; Jeschke U; Hester A
Breast Cancer Res; 2021 Apr; 23(1):45. PubMed ID: 33849622
[TBL] [Abstract][Full Text] [Related]
2. EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases.
Zati Zehni A; Jeschke U; Hester A; Kolben T; Ditsch N; Jacob SN; Mumm JN; Heidegger HH; Mahner S; Vilsmaier T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580276
[TBL] [Abstract][Full Text] [Related]
3. EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.
Semmlinger A; von Schoenfeldt V; Wolf V; Meuter A; Kolben TM; Kolben T; Zeder-Goess C; Weis F; Gallwas J; Wuerstlein R; Hermelink K; Schmoeckel E; Harbeck N; Mayr D; Mahner S; Jeschke U; Ditsch N
BMC Cancer; 2018 Apr; 18(1):431. PubMed ID: 29661238
[TBL] [Abstract][Full Text] [Related]
4. EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer.
Czogalla B; Kuhn C; Heublein S; Schmöckel E; Mayr D; Kolben T; Trillsch F; Burges A; Mahner S; Jeschke U; Hester A
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2519-2527. PubMed ID: 31485769
[TBL] [Abstract][Full Text] [Related]
5. The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients.
Heidegger H; Dietlmeier S; Ye Y; Kuhn C; Vattai A; Aberl C; Jeschke U; Mahner S; Kost B
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753926
[TBL] [Abstract][Full Text] [Related]
6. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
Medrek C; Pontén F; Jirström K; Leandersson K
BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
[TBL] [Abstract][Full Text] [Related]
7. Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review.
Yamaguchi J; Moriuchi H; Ueda T; Kawashita Y; Hazeyama T; Tateishi M; Aoki S; Uchihashi K; Nakamura M
BMC Cancer; 2021 Apr; 21(1):434. PubMed ID: 33879104
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer.
Cha YJ; Kim ES; Koo JS
Breast Cancer Res Treat; 2018 Jul; 170(1):15-25. PubMed ID: 29468486
[TBL] [Abstract][Full Text] [Related]
9. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
Chi Y; Yao L; Hu X; Huang S; Huang N; Li S; Shao Z; Wu J
Oncotarget; 2016 Mar; 7(12):14951-62. PubMed ID: 26908452
[TBL] [Abstract][Full Text] [Related]
10. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
11. The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases.
Dietlmeier S; Ye Y; Kuhn C; Vattai A; Vilsmaier T; Schröder L; Kost BP; Gallwas J; Jeschke U; Mahner S; Heidegger HH
Sci Rep; 2020 Jan; 10(1):1154. PubMed ID: 31980713
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
13. Correlation of sex-determining region Y-box 30 with tumor characteristics and its prognostic value in breast cancer.
Peng H; Luo Y; Wu J; Yin W
J Clin Lab Anal; 2020 Jun; 34(6):e23232. PubMed ID: 32157740
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
15. Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment.
Stefanovic S; Diel I; Sinn P; Englert S; Hennigs A; Mayer C; Schott S; Wallwiener M; Blumenstein M; Golatta M; Heil J; Rom J; Sohn C; Schneeweiss A; Schuetz F; Domschke C
Ann Surg Oncol; 2016 Mar; 23(3):757-66. PubMed ID: 26467455
[TBL] [Abstract][Full Text] [Related]
16. p-mTOR expression is associated with better prognosis in luminal breast carcinoma.
Beca F; Andre R; Martins DS; Bilhim T; Martins D; Schmitt F
J Clin Pathol; 2014 Nov; 67(11):961-7. PubMed ID: 25053543
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2- subtype breast cancer.
Liu L; Chi Y; Chen J; Xue J; Deng L; Huang N; Shao J; Wu J
Sci Rep; 2017 Sep; 7(1):12382. PubMed ID: 28959047
[TBL] [Abstract][Full Text] [Related]
18. Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer.
Agostinetto E; Giordano L; Torrisi R; De Sanctis R; Masci G; Losurdo A; Zuradelli M; Tinterri C; Gatzemeier W; Testori A; Alloisio M; De Rose F; Fernandes B; Santoro A
Clin Breast Cancer; 2020 Aug; 20(4):e481-e489. PubMed ID: 32279915
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
